Search Results - "Gibbens, I"

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis by EISEN, T, AHMAD, T, NATHANSON, K. L, XIA, C, SIMANTOV, R, SCHWARTZ, B, POULIN-COSTELLO, M, O'DWYER, P. J, RATAIN, M. J, FLAHERTY, K. T, GORE, M, KAYE, S, MARAIS, R, GIBBENS, I, HACKETT, S, JAMES, M, SCHUCHTER, L. M

“…The effects of sorafenib--an oral multikinase inhibitor targeting the tumour and tumour vasculature--were evaluated in patients with advanced melanoma enrolled…”
Get full text

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies by Eisen, T, Marais, R, Affolter, A, Lorigan, P, Robert, C, Corrie, P, Ottensmeier, C, Chevreau, C, Chao, D, Nathan, P D, Jouary, T, Harries, M, Negrier, S, Montegriffo, E, Ahmad, T, Gibbens, I, James, M G, Strauss, U P, Prendergast, S, Gore, M E

“…Method: The safety of oral sorafenib up to a maximum protocol-specified dose combined with dacarbazine in patients with metastatic, histologically confirmed…”
Get full text

A Phase I II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma by LARKIN, J. M. G, HUGHES, S. A, BEIRNE, D. A, PATEL, P. M, GIBBENS, I. M, BATE, S. C, THOMAS, K, EISEN, T. G, GORE, M. E

“…Temozolomide is an alkylating agent with activity in the treatment of melanoma metastatic to the brain. Lomustine is a nitrosurea that crosses the blood brain…”
Get full text

A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer by HARRIES, M, MOSS, C, COLE, C, PIZZADA, O, KAYE, S, PERREN, T, GORE, M, HALL, G, EVERARD, M, A'HERN, R, GIBBENS, I, JENKINS, A, SHAH, R

“…A total of 53 women with chemotherapy-naïve stage Ic-IV ovarian cancer were treated with four cycles of carboplatin area under the curve 7 every 3 weeks,…”
Get full text

Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I II trial by ROTHERMUNDT, C, HUBNER, R, AHMAD, T, GIBBENS, I, KEYZOR, C, HABESHAW, T, KAYE, S, GORE, M

“…Platinum-based combination chemotherapy has been proven to be superior to single-agent platinum in the treatment of relapsed ovarian cancer after a…”
Get full text

Attitudes to chemotherapy in patients with ovarian cancer by Penson, R.T., Dignan, F., Seiden, M.V., Lee, H., Gallagher, C.J., Matulonis, U.A., Olson, K., Gibbens, I., Gore, M.E.

“…Background. Recurrent ovarian cancer (OVCA) has become the model for cancer as a chronic disease, yet little is known about what motivates patients and…”
Get full text

Epirubicin-carboplatin-capecitabine (ECarboX) in relapsed ovarian cancer: A phase I/II trial by Hubner, R., Ahmad, T., Rigg, A., Kaye, S., Gibbens, I., Keyzor, C., Prouse, A., Gore, M.

“…Abstract only…”
Get full text

Epirubicin-carboplatin-capecitabine (ECarboX) in relapsed ovarian cancer: A phase I/II trial by Hubner, R., Ahmad, T., Rigg, A., Kaye, S., Gibbens, I., Keyzor, C., Prouse, A., Gore, M.

“…Abstract only…”
Get full text

Phase I trial of BAY 43–9006 (sorafenib) combined with dacarbazine (DTIC) in metastatic melanoma patients by Eisen, T., Ahmad, T., Gore, M. E., Marais, R., Gibbens, I., James, M. G., Schwartz, B., Bergamini, L.

“…Abstract only…”
Get full text